Projects funded by the NCN
Universal vaccine against SARS-CoV-2 variants based on conserved spike protein epitopes – vaccine efficacy studies in vitro and in vivo.
2021/41/B/NZ6/02888
Keywords:
SARS-CoV-2 COVID-19 vaccine virus like particles (VLPs) epitope sHBsAg
Descriptors:
- NZ6_5: Virology
- NZ7_12: Prevention of human diseases
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 1 286 400 PLN
Project start date (Y-m-d): 2022-03-01
Project end date (Y-m-d): 2025-02-28
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.